A detailed history of Blackhawk Capital Partners Llc. transactions in Abbott Laboratories stock. As of the latest transaction made, Blackhawk Capital Partners Llc. holds 26,801 shares of ABT stock, worth $3.06 Million. This represents 1.66% of its overall portfolio holdings.

Number of Shares
26,801
Previous 29,770 9.97%
Holding current value
$3.06 Million
Previous $3.09 Million 1.23%
% of portfolio
1.66%
Previous 1.89%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$100.07 - $118.13 $297,107 - $350,727
-2,969 Reduced 9.97%
26,801 $3.06 Million
Q1 2024

May 01, 2024

BUY
$109.52 - $120.96 $142,595 - $157,489
1,302 Added 4.57%
29,770 $3.38 Million
Q1 2023

May 09, 2023

SELL
$96.86 - $114.01 $46,492 - $54,724
-480 Reduced 1.66%
28,468 $2.88 Million
Q4 2022

Feb 10, 2023

BUY
$95.06 - $111.52 $45,153 - $52,972
475 Added 1.67%
28,948 $3.18 Million
Q2 2022

Aug 08, 2022

BUY
$102.07 - $123.37 $1.4 Million - $1.69 Million
13,694 Added 92.66%
28,473 $3.09 Million
Q1 2022

May 09, 2022

BUY
$114.02 - $139.04 $684 - $834
6 Added 0.04%
14,779 $1.75 Million
Q3 2021

Nov 10, 2021

SELL
$116.66 - $129.06 $296,899 - $328,457
-2,545 Reduced 14.7%
14,773 $1.75 Million
Q2 2021

Aug 06, 2021

BUY
$105.79 - $124.53 $553,916 - $652,039
5,236 Added 43.34%
17,318 $2.08 Million
Q4 2020

Feb 10, 2021

BUY
$105.0 - $114.42 $436,485 - $475,643
4,157 Added 52.45%
12,082 $1.32 Million
Q3 2020

Nov 16, 2020

SELL
$91.64 - $111.29 $538,843 - $654,385
-5,880 Reduced 42.59%
7,925 $725,000
Q2 2020

Aug 04, 2020

BUY
$76.57 - $98.0 $465,469 - $595,742
6,079 Added 78.68%
13,805 $1.09 Million
Q3 2019

Nov 08, 2019

BUY
$81.84 - $88.74 $365,497 - $396,312
4,466 Added 136.99%
7,726 $646,000
Q2 2019

Aug 13, 2019

BUY
$72.88 - $85.0 $26,236 - $30,600
360 Added 12.41%
3,260 $274,000
Q1 2019

May 08, 2019

BUY
$66.22 - $80.06 $192,038 - $232,174
2,900 New
2,900 $232,000
Q4 2018

Feb 04, 2019

SELL
$65.56 - $74.27 $185,797 - $210,481
-2,834 Closed
0 $0
Q2 2018

Aug 09, 2018

SELL
$57.57 - $63.54 $35,060 - $38,695
-609 Reduced 17.69%
2,834 $173,000
Q1 2018

May 15, 2018

BUY
$56.27 - $63.62 $562 - $636
10 Added 0.29%
3,443 $206,000
Q4 2017

Feb 12, 2018

BUY
$53.68 - $57.47 $184,283 - $197,294
3,433
3,433 $196,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Blackhawk Capital Partners Llc. Portfolio

Follow Blackhawk Capital Partners Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blackhawk Capital Partners Llc., based on Form 13F filings with the SEC.

News

Stay updated on Blackhawk Capital Partners Llc. with notifications on news.